take off after the AGM, page-15

I'll be at the meeting this afternoon. Looking forward to it after being very tempted to go to Perth over the last few years. Was in the City two days ago and have scoped out where to park and where it is already.

Mine include if not already answered before I ask.

1. Market Potential/expectation for use in each market starting here in Oz for Ovarian, Lung and Breast cancer tests I specifically want to know % of our population which will benefit from the test(s)
2. Repeat market Potential/expectation ( cervical screening for example was every few years as are Mammograms)
3. Has the Move to the East Coast delivered to the goals set out in Growth Strategy announced 31 July 2109
4. Time frame for LDT Ovarian and Lung and Breast cancer tests ( full expect not to ask this one as it will be given
5. Promotion of the Ovarian, Lung and Breast cancer tests here and OS costs and time frame
6. Third party involvement. we all know about Thermo Fisher- does/has this put constraints on announcements at all

For Q1 I want to know if the LDT is consumer driven, General Practitioners or only specialists, Q2 is really a key. I do not think BD1 tests are one of one hit wonders and will form a part of long term health care regular blood test similar to cholesterol and blood pressure checks we do by the millions every year.

What questions would you like. No such thing as a dumb question Have a great day. I will as I am looking forward to meeting our very cool team